Pharmaceutical Business Review
Anonymous User | Login

Chemizon Expands Collaboration With Takeda

Published: 04-Aug-2009

Research collaboration would continue to utilize Chemizon’s Discovery Platform

Chemizon has reported that Takeda will continue, and further expand its current research collaboration that utilizes Chemizon’s Discovery Platform. The expansion will be effective beginning the 1st of August, 2009.

Tony Piscopio, chairman and CEO of Optomagic, said: “We are pleased that Takeda, one of Chemizon’s earliest collaborators, has chosen to further extend and expand their collaboration with us.

“This third expansion of the Chemizon-Takeda research partnership is a credit to our scientific team, and validates our efforts in achieving the strategic objectives that were laid out by Takeda. We look forward to a long and mutually beneficial relationship,” he added.

Chemizon is a collaborative drug discovery services organization with operations in South Korea, China and the US.

Located in Osaka, Japan, Takeda is a research-based global pharmaceuticals company.

Mail sent successfully

Tell your friend about this article


Please enter a valid email address

Please enter your name

Please enter the mail body


Your Name: *
Your Email: *
Friend's Email: *
Email Body: *
 

Suppliers To This Sector

Browse A-Z

# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

ADAPT Localization

The Translation and Localization Specialists ...

Adis

Independently Evaluated Drug Information ...

Almac

Drug Development Solutions ...

Altiora

To Strive for the Highest ...

Anoto

Providing Unique Technology for Digital Pen and Paper ...

Aptuit

Drug Discovery and Development ...

White Papers

Browse A-Z

# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

CaseBase Management

BaseCon was established in 1999 to support the pharmaceutical sector with innovative IT so ...

SafetyBase Interchange

BaseCon was established in 1999 to support the pharmaceutical sector with innovative IT so ...

ClinicalBase Trial

BaseCon was established in 1999 to support the pharmaceutical sector with innovative IT so ...

Reliable Prediction of White Plasma Levels

Our kinetics & metabolism experts can help you select and further develop your candidate d ...

Kinetics and Metabolism

Our kinetics & metabolism experts can help you select and further develop your candidate d ...

Drug Safety Evaluation

Our kinetics & metabolism experts can help you select and further develop your candidate d ...

Related Companies

Santen Pharmaceutical Co., Ltd.

Santen Pharmaceutical Co., Ltd. (Santen) is a pharmaceutical company based in Japan. Th ...

Takeda Pharmaceutical Company Limited

Takeda Pharmaceutical Company Limited (Takeda) is a global pharmaceutical company mainl ...

Eisai Co., Ltd.

Eisai Co., Ltd. (Eisai) is a Japanese pharmaceutical company focused on researching, de ...

Chugai Pharmaceutical Co. Ltd

Chugai Pharmaceutical Co., Ltd. (Chugai Pharmaceutical) is a pharmaceutical company eng ...

Mochida Pharmaceutical Co., Ltd.

Mochida Pharmaceutical Co., Ltd (Mochida) is a Japan based healthcare company. The com ...

Suppliers Product News

Almac Completes Phase One of Its Expansion Plan to Pharma Services Facilities

New $15m facility will "meet growing business need for its integrated product development and commercial services."

Organisations Throwing Mobile Technology at Problems With Little Consideration of Actual User and Business Needs, Quocirca

Survey reveals detrimental impact on organisational effectiveness and IT expenditure in healthcare and finance across the UK, France, Germany and the US.

Digital Pen and Paper Technology Helps Accelerate Clinical Trials

Digital pen and paper technology captures handwritten clinical data electronically, quickly and securely to save time and cost in drug discovery process.

Aptuit Outlines 2010 Business Priorities at 28th Annual J.P. Morgan Healthcare Conference

Aptuit, Inc., a contract development and manufacturing company, today will provide an update on 2010 business priorities and discuss its integrated service offerings at the 28th Annual J.P. Morgan Healthcare Conference in San Francisco.

Aptuit Publishes Study which Demonstrates the Value of Early Insights into the Characterisation of Drug Compounds

New research on the solid-state characterisation of finasteride clearly outlines a systematic approach to characterising and monitoring active pharmaceutical ingredients

Aptuit Launches Program to Accelerate Early Stage Drug Development

Aptuit INDiGO™ accelerates drug development from pre-clinical candidate selection to regulatory filing on a fixed timeline and price

Free Newsletter Sign-up

Sign up, and we will send you a free Pharmaceutical report on “ Combination Products – Evolution of the Medical Equipment Industry” from GlobalData worth $750

Please enter a valid email address